Encompass Health sets results date and EHC stock costs EUR 109.50
Published on 10/08/2026 at 18:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Encompass Health scheduled third-quarter results for October 28, 2026, followed by an investor call on October 29.
- Second-quarter revenue reached USD 1.60 billion, while adjusted earnings per share came in at USD 1.55 versus USD 1.48 expected.
- The stock was at EUR 109.50 at Lang & Schwarz on October 8, 2026, plus 0.46 percent versus the prior close.
Encompass Health (ISIN US29261A1007) was trading at EUR 109.50 at Lang & Schwarz after-hours on October 8, 2026. The company had scheduled its third-quarter report for October 28, 2026, giving investors a defined date for the next test of its rehabilitation growth strategy.
Three expansion steps in 2026
On September 15, 2026, Encompass Health opened a 50-bed inpatient rehabilitation hospital in Pennsylvania. The facility is the company's 11th location in the state.
On September 24, 2026, Encompass Health announced a 24-bed small-format hospital in Conroe, Texas, alongside a 60-bed replacement hospital in The Woodlands. The projects extend capacity while preserving the existing Woodlands operation during construction.
On October 1, 2026, Encompass Health announced that third-quarter results for the period ended September 30, 2026, would be released after the market close on October 28, 2026.
What will the report test?
The second quarter provides the latest operating benchmark. Yahoo Finance lists revenue of USD 1.60 billion for the second quarter of 2026 and adjusted earnings per share of USD 1.55, above the USD 1.48 consensus estimate. The comparison puts execution, patient volumes and labor costs at the center of the October update.
Encompass Health's expansion pipeline also gives the results a capacity angle. Its official investor page describes a network of 176 hospitals and a plan to open 6 to 10 new hospitals and add 80 to 120 beds each year through 2027.
Next dates for EHC investors
The next reporting date is October 28, 2026, after the market close. The following investor conference call is scheduled for October 29, 2026, at 10:00 a.m. ET, according to Encompass Health.
Stock stays below its US yearly high
The Lang & Schwarz quote was EUR 109.50 on October 8, 2026 at 6:28 p.m. CEST, plus 0.46 percent versus the prior close of EUR 109.00 on October 7, 2026. On the NYSE, the stock was quoted at USD 122.21 on October 8, 2026, while its 52-week range was USD 92.77 to USD 127.99.
The further course of trading is shown by the continuously updated real-time quote of Encompass Health stock.
Encompass Health stock facts
- Company: Encompass Health Corporation
- ISIN: US29261A1007
- Ticker: EHC
- Primary exchange: NYSE
- Price Lang & Schwarz as of October 8, 2026, 6:28 p.m. CEST: EUR 109.50
- Change versus prior close: plus 0.46 percent
- Prior close Lang & Schwarz October 7, 2026: EUR 109.00
- Market capitalization: USD 12.1 billion as of October 8, 2026
- 52-week range: USD 92.77-127.99 as of October 8, 2026
- Sector / Industry: Healthcare / Medical Care Facilities
- Next earnings date: October 28, 2026
Market context: Market report S&P 500.
